Tue, Apr 23, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds’ favorite stocks post worst returns this year

Tuesday, November 24, 2015

Komfie Manalo, Opalesque Asia:

With most of their favorite stocks posting worst performance since the financial crisis, hedge fund managers are hit with poor returns, according to Goldman Sachs’ latest Hedge Fund VIP list.

The data said that hedge funds’ position in health care companies, particularly Valeant Pharmaceuticals, hurt the most, reported Reuters. Aside from Valeant, included in the 50 most heavily owned stocks of hedge fund managers are Facebook, Netflix and Cheniere Energy, which lost 2.4% since January while the Standard & Poor's 500 stock index rose 3% during the same period.

"Health-care stocks within the basket, most notably VRX (Valeant), were responsible for nearly 70 percent of the basket's negative return," Goldman Sachs said.

Several hedge funds, including Pershing Square Capital and Paulson & Co., as well as 22 institutional investors lost money when Valeant’s stocks dropped 70% since August this year.

Barry Rosenstein reported that he ditched his entire stake in Valeant Pharmaceuticals right before the shares plunged. The drugmaker's shares had been a big performance drive......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1